Navigation Links
Dr. Julian Henley MD Presents 'BioMatrix Lift'

NEW HAVEN, Conn., Nov. 2 /PRNewswire/ -- Renowned plastic surgeon Dr. Julian Henley will be taking consultations in New York City, Darien, CT and New Haven, CT for potential candidates of his revolutionary new procedure the BioMatrix Lift.

For over 20 years, Dr. Henley has stood at the forefront of his field's exciting evolution, developing new techniques to improve results and expand possibilities. The culmination of two years of research, the BioMatrix Lift represents the latest in surgical facial rejuvenation procedures designed to provide a healthier and more youthful appearance.

"The BioMatrix Lift uses established techniques combined with a biological matrix that regenerates tissue in areas where tissue is deficient," explains Dr. Henley. "It allows us to improve areas surgeons have previously been unable to improve, especially around the eyes, the orbit and eye socket."

Facelifts have traditionally been a tightening operation or a repositioning operation where if something is hanging you lift it up. But a youthful appearance depends on a certain degree of pliancy and fullness; if you tighten skin and remove wrinkles you can have an older looking face.

As a result, many non-surgical physicians, like dermatologists, have advocated non-surgical facelifts, which increase volume through injectibles to achieve desired results.

"What I'm proposing is not that one specialty is right or the other is wrong," says Dr. Henley, "because when you combine these approaches you can achieve even more remarkable results. The BioMatrix Lift allows us to improve the aesthetic benefits of the procedure by stimulating the patient's own tissue regeneration."

The biological matrix employed by Dr. Henley is derived from natural materials. All the cells are removed but its growth factors remain preserved; these growth factors provide the structure to facilitate the rebuilding of normal tissue. While this technology has already been used to repair hearts, diaphragms and hernia, Dr. Henley is the first to use it for cosmetic applications.

"Medicine is competitive but it's also collaborative science," says Dr. Henley. "The BioMatrix Lift is a new technology I hope will be adopted over time by other practitioners, for whom it will give a greater benefit to their patients."

Dr. Julian Henley visit

    Contact Info

    Dr. Julian Henley
    Aesthetic Plastic Surgery Center
    1423 Chapel St.
    New Haven, CT 06511
    Contact: Dr. Julian Henley
    Tel: (203) 787-4647

    Close-Up TV News, (631) 421-6072

SOURCE Dr. Julian Henley

SOURCE Dr. Julian Henley
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
2. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
3. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
4. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
5. CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein
6. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
7. Targanta Presents First Data Demonstrating In Vitro Activity and In Vivo Efficacy of Prodrugs in Osteomyelitis Models
8. Wyeth Presents Phase 3 Fracture Data for Bazedoxifene, an Investigational Therapy for Osteoporosis
9. Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
10. Surface Logix Presents Positive Phase 1 Repeat-Dose Trial Data on SLx-4090 at The 16th International Symposium on Drugs Affecting Lipid Metabolism
11. Wyeth Presents New Phase 3 Data and Updates Regulatory Timing for NDA Filing of Bazedoxifene/Conjugated Estrogens
Post Your Comments:
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
(Date:6/24/2016)... -- Research and Markets has announced the addition ... report to their offering. ... The World Market for Companion Diagnostics covers the world ... in the report includes the following: , ... by Region (N. America, EU, ROW), 2015-2020 , World ...
(Date:6/24/2016)... Belgium , June 24, 2016 ... the appointment of Dr. Edward Futcher ... Non-Executive Director, effective June 23, 2016.Dr. Futcher was ... Nominations and Governance Committees.  As a non-executive member ... independent expertise and strategic counsel to VolitionRx in ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, ... at Work award to iHire in recognition of their exemplary accomplishments in worksite health ... annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World ... with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all ... brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented ... in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor the ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this award, ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm ... sciences executive with extensive sequencing and genomics experience, as Vice President of North American ... Hill will be responsible for leading the sales team in the commercialization of the ...
Breaking Medicine News(10 mins):